ACAugusto Dulanto Chiang

Augusto Dulanto Chiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Augusto Dulanto Chiang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • A. Launay

    Bacterial Pathogenesis and Antimicrobial Resistance Unit, LCIM, NIAID, Bethesda, USA

    1 shared publication
  • Adrian M Zelazny

    Department of Laboratory Medicine, Clinical Center, NIH, Bethesda, Maryland, USA

    1 shared publication
  • Alex Mainor

    Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University

    1 shared publication
  • Andrea Lisco

    National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA

    1 shared publication
  • Ashley Zeoli

    Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center

    1 shared publication
  • Breann Zeches

    Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center

    1 shared publication

Latest Publications

  • Open Access

    Fusarium falciforme keratitis in a corneal transplant recipient treated successfully with fosmanogepix and intracameral amphotericin B

    by Ashley Zeoli, Christine Shieh, Karen C. Bloch, Lili Tao, Alex Mainor, Christo Cimino, Breann Zeches, Augusto Dulanto Chiang

    Background: Ocular fungal infections are a major cause of vision loss worldwide. Fusarium spp., a leading cause of fungal keratitis, is often difficult to treat. There are no current standardized treatment guidelines for fungal keratitis. We present a case of Fusarium spp. keratitis that was treated with fosmanogepix and intracameral amphotericin B, highlighting additional treatment options in difficult-to-treat cases. To our knowledge, this is the first report of fosmanogepix use in Fusarium keratitis. Case Summary: A 72-year-old man presented with 2 weeks of right eye pain and redness and was diagnosed with Fusarium falciforme keratitis via ocular fungal culture. He failed multiple topical, oral, and intraocular antifungal agents, and required corneal transplantation. Histopathology from his explant showed hyaline hyphae with occasional sickle-shaped conidia, consistent with Fusarium spp. The infection recurred in the corneal allograft despite intravitreal voriconazole, intraocular amphotericin B, and topical natamycin. Ultimately, he underwent successful treatment with fosmanogepix, a first-in-class antifungal agent. Conclusion: Our case illustrates the challenges of managing Fusarium keratitis and the potential role of novel antifungal agents, such as fosmanogepix, as adjuncts to established intraocular and topical therapy in the setting of clinical failure.


  • Open Access

    Updating CMV protocols in lung transplant patients: a single-center case study modeling use of generative AI for antimicrobial stewardship protocol development and economic impact analysis

    by Kyle T. Enriquez, Augusto Dulanto Chiang, Casey Smiley, Milner Staub

    Objective: Antimicrobial Stewardship Programs (ASPs) need healthcare economic analyses to support and inform ASP strategies. This work aimed to determine whether widely available artificial intelligence (AI) platforms like Microsoft Copilot TM could facilitate healthcare economics analyses for ASP programs without dedicated healthcare economic supports. Design: AI (Microsoft Copilot TM ) was prompted to develop a cytomegalovirus prophylaxis protocol for lung transplant recipients using only PubMed-indexed articles. Copilot TM was then prompted to produce probabilistic samples of simulated patients from aggregate statistics of a 165-patient cohort from Vanderbilt University Medical Center and to analyze cost-effectiveness across four distinct cytomegalovirus prophylaxis protocols, including its own. Setting: Tertiary care academic medical center, including outpatient and inpatient environments. Patients or participants: Simulated patient data was developed via random, single-blind, probabilistic selection from pre-defined aggregate cohort statistics. Results: The AI-generated prophylaxis protocol was evidence-based without hallucination, but this conservative protocol relied on outdated evidence and was associated with significant increases in expected per-patient cost (mean +$4740, P < .01) compared to recent guideline-based and institutional protocols. AI independently identified and executed sensitivity analyses, which revealed that in this simplified model, letermovir use had a large impact on expected per-patient cost. Conclusions: The AI-proposed protocol was less cost-effective, but data suggest that careful prompting can provide appropriate PubMed-indexed literature to support ASP protocol development. Additionally, CoPilot TM provided a thorough cost-effectiveness analysis comparing all potential and existing protocols. With appropriate oversight, AI and Microsoft Copilot TM can conduct healthcare economic analyses suitable for ASP strategic planning and implementation.


  • Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology

    by David C. Gaston, Augusto Dulanto Chiang, Kevin Dee, Daniel Dulek, Ritu Banerjee, Romney M. Humphries


  • Open Access

    In vivo evolution of an emerging zoonotic bacterial pathogen in an immunocompromised human host

    by A. Launay, C.-J. Wu, A. Dulanto Chiang, J.-H. Youn, P. P. Khil, J. P. Dekker

    Zoonotic transfer of animal pathogens to human hosts can generate novel agents, but the genetic events following such host jumps are not well studied. Here we characterize the mechanisms driving adaptive evolution of the emerging zoonotic pathogen Bordetella hinzii in a patient with interleukin-12 receptor β1 deficiency. Genomic sequencing of 24 B. hinzii isolates cultured from blood and stool over 45 months revealed a clonal lineage that had undergone extensive within-host genetic and phenotypic diversification. Twenty of 24 isolates shared an E9G substitution in the DNA polymerase III ε-subunit active site, resulting in a proofreading deficiency. Within this proofreading-deficient clade, multiple lineages with mutations in DNA repair genes and altered mutational spectra emerged and dominated clinical cultures for more than 12 months. Multiple enzymes of the tricarboxylic acid cycle and gluconeogenesis pathways were repeatedly mutated, suggesting rapid metabolic adaptation to the human environment. Furthermore, an excess of G:C > T:A transversions suggested that oxidative stress shaped genetic diversification during adaptation. We propose that inactivation of DNA proofreading activity in combination with prolonged, but sub-lethal, oxidative attack resulting from the underlying host immunodeficiency facilitated rapid genomic adaptation. These findings suggest a fundamental role for host immune phenotype in shaping pathogen evolution following zoonotic infection.


  • Open Access

    Disseminated Mycobacterium marinum in Human Immunodeficiency Virus Unmasked by Immune Reconstitution Inflammatory Syndrome

    by Maura Manion, Augusto Dulanto Chiang, Luxin Pei, Chun-Shu Wong, Pavel Khil, Dima A Hammoud, Megan Anderson, Elizabeth Laidlaw, Safia Kuriakose, Andrea Lisco, et al.

    Distinguishing disseminated Mycobacterium marinum from multifocal cutaneous disease in persons with human immunodeficiency virus/AIDS can present a diagnostic challenge, especially in the context of immune reconstitution inflammatory syndrome (IRIS). In this work, we demonstrate the utility of flow cytometry and whole genome sequencing (WGS) to diagnose disseminated M. marinum unmasked by IRIS following initiation of antiretroviral therapy. Flow cytometry demonstrated robust cytokine production by CD4 T cells in response to stimulation with M. marinum lysate. WGS of isolates from distinct lesions was consistent with clonal dissemination, supporting that preexisting disseminated M. marinum disease was uncovered by inflammatory manifestations, consistent with unmasking mycobacterial IRIS.


  • Late sequelae of left ventricular assist device infection presenting after heart transplant

    by A. Dulanto Chiang, N. Narsana, M.E. Ruiz

    The long‐term use of left ventricular assist devices (LVADs) is becoming more common among the end‐stage heart failure population. At the time of heart transplantation, most of the LVAD is removed, but some of its components might be retained. Retained LVAD prosthetic material can lead to serious infection post heart transplant. We report 4 such cases. Our goal is to highlight the importance of complete prosthetic material removal at the time of cardiac transplant to prevent late‐onset infection, especially in patients with preceding infection, but also in patients without evidence of LVAD infection prior to orthotopic heart transplantation.